Corrigendum: Network pharmacology-based prediction of active compounds in Wenyang Jiedu Huayu formula acting on acute-on-chronic liver failure with experimental support in vitro and in vivo(Front. Pharmacol., (2022), 13, (1003479), 10.3389/fphar.2022.1003479)
[Mo, Yang] Hunan Univ Tradit Chinese Med, Acad Affairs Off, Changsha, Peoples R China.
通讯机构：
[Sun, K.-W.] D
Department of Hepatology, China
语种：
英文
关键词：
Acute-on-chronic liver failure (ACLF);Wenyang Jiedu Huayu (WYJDHY) formula;Network Pharmacology;Atractylenolide I (AT-1);rat hepatocytes;ACLF rat model
In the published article, there was an error in the Funding statement . The funding statement for the National Natural Science Foundation of China was displayed as “(8197152432 and 82104809).” The correct Funding statement appears below.
机构署名：
本校为第一机构
院系归属：
第一中医临床学院
摘要：
In the published article, there was an error in the Funding statement. The funding statement for the National Natural Science Foundation of China was displayed as “(8197152432 and 82104809).” The correct Funding statement appears below. “Funding This study was supported by the National Natural Science Foundation of China (81973833 and 82104809), and the Hunan University of Chinese Medicine Graduate student innovation topics (2020CX18).” The authors apologize for this error and state that this does not change the scientific conclusions of th...
